Ignite Creation Date:
2024-05-06 @ 9:16 AM
Last Modification Date:
2024-10-26 @ 12:12 PM
Study NCT ID:
NCT02941926
Status:
COMPLETED
Last Update Posted:
2023-10-24
First Post:
2016-10-20
Brief Title:
Study to Assess the Safety and Efficacy of Ribociclib LEE011 in Combination With Letrozole for the Treatment of Men and PrePostmenopausal Women With HR HER2- aBC
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-20
First Submit QC Date:
October 20 2016
Study First Post Date:
2016-10-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-05-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2020-04-18
Disp First Submit QC Date:
May 19 2020
Disp First Post Date:
2020-05-21
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-10-23
Last Update Post Date:
2023-10-24
Last Update Post Date Type:
ACTUAL